tradingkey.logo

tradingkey.logo
怜玢


Verastem Inc

VSTM
りォッチリストに远加
8.180USD
-0.260-3.08%
終倀 11-13 16:00ET
993.22M時䟡総額
損倱額盎近12ヶ月PER

Verastem Incに぀いお 䌁業名

Verastem, Inc. is a late-stage development biopharmaceutical company, which focuses on the development and commercialization of new medicines to improve the lives of patients diagnosed with ras sarcoma (RAS)/ mitogen-activated pathway kinase (MAPK) pathway-driven cancers. Its product candidates include avutometinib and defactinib. Avutometinib is an oral RAF/MEK clamp that inhibits MEK1/2 kinase activities and induces inactive complexes of MEK with A-Raf proto-oncogene, potentially serine/threonine kinase (ARAF), B-Raf proto-oncogene serine/threonine kinase (BRAF) and C-raf proto-oncogene serine/threonine kinase, creating antitumor response through maximal RAS/MAPK pathway inhibition. Defactinib is an oral, selective inhibitor of FAK and proline-rich tyrosine kinase (PYK2), the two members of the focal adhesion kinase family of non-receptor protein tyrosine kinases. FAK and PYK2 integrate signals from integrin and growth factor receptors to regulate cell proliferation.

Verastem Inc プロフィヌル


䌁業コヌドVSTM
䌚瀟名Verastem Inc
䞊堎日Nov 08, 2011
最高経営責任者「CEO」Paterson (Daniel W)
埓業員数78
蚌刞皮類Ordinary Share
決算期末Nov 08
本瀟所圚地117 Kendrick Street
郜垂NEEDHAM
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号02494
電話番号17812924200
りェブサむトhttps://www.verastem.com/
䌁業コヌドVSTM
䞊堎日Nov 08, 2011
最高経営責任者「CEO」Paterson (Daniel W)

Verastem Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Daniel W. (Dan) Paterson
Mr. Daniel W. (Dan) Paterson
Director
Director
271.04K
-16.28%
Mr. Brian M. Stuglik
Mr. Brian M. Stuglik
Director
Director
136.45K
+26.38%
Mr. Michael P. Bailey
Mr. Michael P. Bailey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
108.00K
--
Mr. Daniel (Dan) Calkins
Mr. Daniel (Dan) Calkins
Chief Financial Officer
Chief Financial Officer
54.77K
-4.69%
Ms. Michelle Robertson
Ms. Michelle Robertson
Independent Director
Independent Director
51.97K
+69.27%
Mr. Anil Kapur
Mr. Anil Kapur
Independent Director
Independent Director
51.97K
+69.27%
Mr. Matthew E. (Matt) Ros
Mr. Matthew E. (Matt) Ros
Chief Operating Officer
Chief Operating Officer
50.00K
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Director
Director
40.98K
+5.66%
Dr. Michael G. Kauffman, M.D., Ph.D.
Dr. Michael G. Kauffman, M.D., Ph.D.
President - Development, Director
President - Development, Director
16.52K
+51.75%
Dr. Eric K. Rowinsky, M.D.
Dr. Eric K. Rowinsky, M.D.
Independent Director
Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Daniel W. (Dan) Paterson
Mr. Daniel W. (Dan) Paterson
Director
Director
271.04K
-16.28%
Mr. Brian M. Stuglik
Mr. Brian M. Stuglik
Director
Director
136.45K
+26.38%
Mr. Michael P. Bailey
Mr. Michael P. Bailey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
108.00K
--
Mr. Daniel (Dan) Calkins
Mr. Daniel (Dan) Calkins
Chief Financial Officer
Chief Financial Officer
54.77K
-4.69%
Ms. Michelle Robertson
Ms. Michelle Robertson
Independent Director
Independent Director
51.97K
+69.27%
Mr. Anil Kapur
Mr. Anil Kapur
Independent Director
Independent Director
51.97K
+69.27%

よくある質問

Verastem Incの䞊䜍5名の株䞻は誰ですか


Verastem Incの䞊䜍5名の株䞻は以䞋のずおりです。Mr. Daniel W. (Dan) Paterson

Verastem IncVSTMの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Verastem Incの株匏を保有しおいる機関は295瀟あり、保有株匏の総垂堎䟡倀は玄83.43Mで、党䜓の95.00%を占めおいたす。2025Q4ず比范しお、機関の持ち株は1074267.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。